MUSTANG BIO, INC. Lease, Cost
MUSTANG BIO, INC. (MBIO) reported Lease, Cost of $195.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-19
- MUSTANG BIO, INC. lease, cost for the quarter ending 2025-12-31 was $58.00K, a 71.98% decline year-over-year.
- MUSTANG BIO, INC. lease, cost for the quarter ending 2025-09-30 was -$17.00K, a 108.13% decline year-over-year.
- MUSTANG BIO, INC. lease, cost for the quarter ending 2025-06-30 was $17.00K.
- MUSTANG BIO, INC. lease, cost for the quarter ending 2025-03-31 was $137.00K, a 104.48% increase year-over-year.
- MUSTANG BIO, INC. lease, cost for fiscal 2025 was $195.00K, a 58.42% decline from fiscal 2024.
- MUSTANG BIO, INC. lease, cost for fiscal 2024 was $469.00K, a 48.23% decline from fiscal 2023.
- MUSTANG BIO, INC. lease, cost for fiscal 2023 was $906.00K, a 13.96% decline from fiscal 2022.
- MUSTANG BIO, INC. lease, cost for fiscal 2022 was $1.05M, a 15.21% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $41.00K derived: sum of 2 quarters · filed 2026-03-19 | $58.00K derived: sum of 3 quarters · filed 2026-03-19 | $195.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $137.00K 10-Q · filed 2025-11-07 | $344.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $154.00K 10-Q · filed 2025-08-08 | $361.00K derived: sum of 3 quarters · filed 2026-03-19 | $570.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-03-31 | $137.00K 10-Q · filed 2025-05-14 | $344.00K derived: sum of 2 quarters · filed 2026-03-19 | $553.00K derived: sum of 3 quarters · filed 2026-03-19 | $539.00K derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $416.00K derived: sum of 2 quarters · filed 2026-03-19 | $402.00K derived: sum of 3 quarters · filed 2026-03-19 | $469.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $195.00K derived: sum of 2 quarters · filed 2025-11-07 | $262.00K 10-Q · filed 2025-11-07 | $32.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $53.00K 10-Q · filed 2025-08-08 | -$177.00K derived: sum of 3 quarters · filed 2025-08-08 | $184.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $67.00K 10-Q · filed 2025-05-14 | $66.00K 10-Q · filed 2024-05-15 | -$163.00K derived: sum of 2 quarters · filed 2025-05-14 | $198.00K derived: sum of 3 quarters · filed 2025-05-14 | $552.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $131.00K derived: sum of 2 quarters · filed 2025-03-28 | $485.00K derived: sum of 3 quarters · filed 2025-03-28 | $906.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $715.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.14M 10-Q · filed 2024-11-08 | $1.48M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $775.00K 10-Q · filed 2024-08-13 | $1.12M derived: sum of 3 quarters · filed 2024-08-13 | $1.45M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $421.00K 10-Q · filed 2024-05-15 | $767.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.09M derived: sum of 3 quarters · filed 2024-05-15 | $1.32M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $673.00K derived: sum of 2 quarters · filed 2024-03-11 | $902.00K derived: sum of 3 quarters · filed 2024-03-11 | $1.05M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $556.00K derived: sum of 2 quarters · filed 2023-11-14 | $707.00K 10-Q · filed 2023-11-14 | $942.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $380.00K 10-Q · filed 2023-08-14 | $615.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $151.00K 10-Q · filed 2023-05-12 | $386.00K derived: sum of 2 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $914.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $679.00K 10-Q · filed 2022-11-14 | ||||
| 2021-03-31 | $223.00K 10-Q · filed 2021-05-14 | $446.00K derived: sum of 2 quarters · filed 2022-03-23 | $628.00K derived: sum of 3 quarters · filed 2022-03-23 | $706.00K derived: sum of 4 quarters · filed 2022-03-23 | |
| 2020-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $405.00K derived: sum of 2 quarters · filed 2022-03-23 | $483.00K derived: sum of 3 quarters · filed 2022-03-23 | $800.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $260.00K derived: sum of 2 quarters · filed 2020-11-06 | $577.00K 10-Q · filed 2020-11-06 | $851.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $395.00K 10-Q · filed 2020-08-10 | $669.00K derived: sum of 3 quarters · filed 2021-05-14 | $871.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-03-31 | $317.00K 10-Q · filed 2021-05-14 | $591.00K derived: sum of 2 quarters · filed 2021-05-14 | $793.00K derived: sum of 3 quarters · filed 2021-05-14 | $998.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $476.00K derived: sum of 2 quarters · filed 2021-03-24 | $681.00K derived: sum of 3 quarters · filed 2021-03-24 | $996.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $202.00K 10-Q · filed 2019-11-12 | $407.00K derived: sum of 2 quarters · filed 2020-08-10 | $722.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $520.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $315.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |